| 中文名称: | 6-苄氧基-9-((1S,3R,3S)-4-苄氧基-3-苄氧基甲基-2-亚甲基环戊基)-N-((4-甲氧基苯基)二苯基甲基)-9H-嘌呤-2-胺 |
| 中文别名: | 恩替卡韦中间体N7;6-苄氧基-9-((1S,3R,3S)-4-苄氧基-3-苄氧基甲基-2-亚甲基环戊基)-N-((4-甲氧基苯基)二苯基甲基)-9H-嘌呤-2-胺;恩替卡韦E-7,6-苄氧基-9-((1S,3R,3S)-4-苄氧基-3-苄氧基甲基-2-亚甲基环戊基)-N-((4-甲氧基苯基)二苯基甲基)-9H-嘌呤-2-胺;1-烯丙基哌嗪;6-苄氧基-9-((1S,3R,3S)-4-苄氧基-3-苄氧基甲基-2-亚甲基环戊基)-N-((4-甲氧基苯基)二;恩替卡韦 中间体-7;恩替卡韦-7;恩替卡韦杂质3;恩替卡韦中间体6;恩替卡韦中间体7;6-(苄氧基)-9-((1S,3R,4S)-4-(苄氧基)-3-(苄氧基甲基)-2-亚甲基环戊基)-N-((4-甲氧基苯基)二苯基甲基)-9H-嘌呤-2-胺;恩替卡韦中间体七 |
| smiles: | O(C([H])([H])C1C([H])=C([H])C([H])=C([H])C=1[H])[C@@]1([H])C([H])([H])[C@@]([H])(C(=C([H])[H])[C@]1([H])C([H])([H])OC([H])([H])C1C([H])=C([H])C([H])=C([H])C=1[H])N1C([H])=NC2C(=NC(N([H])C(C3C([H])=C([H])C([H])=C([H])C=3[H])(C3C([H])=C([H])C([H])=C([H])C=3[H])C3C([H])=C([H])C(=C([H])C=3[H])OC([H])([H])[H])=NC1=2)OC([H])([H])C1C([H])=C([H])C([H])=C([H])C=1[H] |
| 英文名称: | 6-(Benzyloxy)-9-((1S,3S)-4-(benzyloxy)-3-((benzyloxy)methyl)-2-methylenecyclopentyl)-N-((4-methoxyphenyl)diphenylmethyl)-9H-purin-2-amine |
| 英文别名: | 6-(Benzyloxy)-9-((1S,3S)-4-(benzyloxy)-3-((benzyloxy)methyl)-2-methylenecyclopentyl)-N-((4-methoxyphenyl)diphenylmethyl)-9H-purin-2-amine;6-(Benzyloxy)-9-(1S,3R,3S)-4-(benzyloxy)-3-(benzyoxymethyl)-2-methylenecyclopentyl)-N-N-(4-methyoxyphenyl)diaphenylmethyl)-9H-purin-2-amine;6-(benzyloxy)-9-(1S,3R,3S)-4-(benzyloxy)_3-(benzyoxymethyl)-2-methylenecyclopentyl)-N-N -(4-methyoxyphenyl)diaphenylmethyl)-9H-purin-2-amino;6-(Benzyloxy)-9-((1S,3R,3S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclopentyl)-N-((4-methoxyphenyl)diphenylmethyl)-9H-purin-2-amine;Entecavir intermediate N7;6-(BENZYLOXY)-9-((1S,3R,3S)-4-(BENZYLOXY)-3-(BENZYLOXYMETHYL)-2-METHYLENECYCLOPENTYL)-N-((4-METHOXYPHENYL)DIPHENYLMETHY...;6-(Benzyloxy)-9-((1S,3S)-4-(benzyloxy)-3-((benzyloxy)methyl)-2-methylene-cyclopenyl)-N-((4-methoxyphenyl)diphenylmethyl)-9H-purin-2-amine;6-(Benzyloxy)-9-((1S,3S)-4-(benzyloxy)-3-((benzyloxy)methyl)-2-methylene-cyclopenyl)-N-((4-methoxyphenyl)diphenylmethyl...;9H-Purin-2-amine, N-[(4-methoxyphenyl)diphenylmethyl]-9-[2-methylene-4-(phenylmethoxy)-3-[(phenylmethoxy)methyl]cyclopentyl]-6-(phenylmethoxy)-, [1S-(1a,3a,4b)]-;Entecavir Intermediate VII;Entecavir N7;N-[(4-methoxyphenyl)-diphenylmethyl]-9-[(1S,3S)-2-methylidene-4-phenylmethoxy-3-(phenylmethoxymethyl)cyclopentyl]-6-phenylmethoxypurin-2-amine;6-(Benzyloxy)-9-((1S,3S)-4-(benzyloxy)-3-((benzyloxy)methyl)-2-methylenecyclopentyl)-N-((4-methoxyph;I06-2209;9H-Purin-2-amine,N-[(4-methoxyphenyl)diphenylmethyl]-9-[2-methylene-4-(phenylmethoxy)-3-[(phenylmethoxy)methyl]cyclopentyl]-6-(phenylmethoxy)-,[1S-(1a,3a,4b)]- (9CI);6-(benzyloxy)-9-((1S,3R,4S)-4-(benzyloxy)-3-((benzyloxy)methyl)-2-methylenecyclopentyl)-N-((4-methoxyphenyl)diphenylmethyl)-9H-purin-2-amine;entecavir-7;217B809;6-(benzyloxy)-9-((1S,3R,4S)-4-(benzyloxy)-3-((benzyloxy)met;hyl)-2-methylenecyclopentyl)-N-((4-methoxyphenyl)diphenyl;N-[(4-Methoxyphenyl)-diphenylmethyl]-9-[(1S,3R,4S)-2-methylidene-4-phenylmethoxy-3-(phenylmethoxymet;N-[(4-Methoxyphenyl)-diphenylmethyl]-9-[(1S,3R,4S)-2-methylidene-4-phenylmethoxy-3-(phenylmethoxymethyl)cyclopentyl]-6-phenylmethoxypurin-2-amine |
| CAS号: | 142217-80-9 |
| 分子式: | C53H49N5O4 |
| 分子量: | 819.99 |
| 密度: | |
| 熔点: | |
| 沸点: | |
| 闪点: | |
| 水溶性: | |
| 蒸气压: |
6-苄氧基-9-((1S,3R,3S)-4-苄氧基-3-苄氧基甲基-2-亚甲基环戊基)-N-((4-甲氧基苯基)二苯基甲基)-9H-嘌呤-2-胺
英文名:
6-(Benzyloxy)-9-((1S,3S)-4-(benzyloxy)-3-((benzyloxy)methyl)-2-methylenecyclopentyl)-N-((4-methoxyphenyl)diphenylmethyl)-9H-purin-2-amine
别名:恩替卡韦中间体N7;6-苄氧基-9-((1S,3R,3S)-4-苄氧基-3-苄氧基甲基-2-亚甲基环戊基)-N-((4-甲氧基苯基)二苯基甲基)-9H-嘌呤-2-胺;恩替卡韦E-7,6-苄氧基-9-((1S,3R,3S)-4-苄氧基-3-苄氧基甲基-2-亚甲基环戊基)-N-((4-甲氧基苯基)二苯基甲基)-9H-嘌呤-2-胺;1-烯丙基哌嗪;6-苄氧基-9-((1S,3R,3S)-4-苄氧基-3-苄氧基甲基-2-亚甲基环戊基)-N-((4-甲氧基苯基)二;恩替卡韦 中间体-7;恩替卡韦-7;恩替卡韦杂质3;恩替卡韦中间体6;恩替卡韦中间体7;6-(苄氧基)-9-((1S,3R,4S)-4-(苄氧基)-3-(苄氧基甲基)-2-亚甲基环戊基)-N-((4-甲氧基苯基)二苯基甲基)-9H-嘌呤-2-胺;恩替卡韦中间体七
商品编号:R059239-100mg
规格:100mg
纯度:97%
CAS号: 142217-80-9
分子式:C53H49N5O4
分子量:819.99
| 价格 |
¥ 130.00
(请 登录 会员查看折扣价)
|
| 货期 | 5~7个工作日 |
数量
搜索质检报告(COA)
搜索MSDS
相关产品


















